Eli Lilly & Co. said it continues to expect 2012 earnings of $3.30 to $3.40 per share. The current consensus earnings estimate is $3.40 per share for the year ending December 31, 2012.

Raises Guidance In-line with Estimates

FY 2013

1/29/20136:30:00 AM

$3.82 to $3.97

3.2%

2.5%

Guidance:

Consensus:

Eli Lilly Raises Guidance, but Remains In-line with Estimates

Eli Lilly & Co. said it now expects 2013 non-GAAP earnings of $3.82 to $3.97 per share and continues to expect revenue of $22.6 billion to $23.4 billion. The company's previous guidance was for earnings of $3.75 to $3.90 per share and the current consensus earnings estimate is $3.84 per share on revenue of $22.83 billion for the year ending December 31, 2013.

Reaffirms

FY 2013

4/24/20136:30:00 AM

$3.82 to $3.97

$22.6 bil to $23.4 bil

$3.90

$23.06 bil

-3.8%

-6.3%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2013 earnings of $3.82 to $3.97 per share on revenue of $22.6 billion to $23.4 billion. The current consensus earnings estimate is $3.90 per share on revenue of $23.06 billion for the year ending December 31, 2013.

EPS Above Estimates

FY 2013

7/24/20136:30:00 AM

$4.05 to $4.15

$22.6 bil to $23.4 bil

$3.92

$22.81 bil

3.0%

2.1%

Guidance:

Consensus:

Eli Lilly Raises Earnings Guidance

Eli Lilly & Co. said it now expects 2013 earnings of $4.05 to $4.15 per share and continues to expect revenue of $22.6 billion to $23.4 billion. The company's previous guidance was earnings of $3.82 to $3.97 per share and the current consensus earnings estimate is $3.92 per share on revenue of $22.81 billion for the year ending December 31, 2013.

Narows Guidance

FY 2013

10/23/20136:30:00 AM

$4.10 to $4.15

$22.6 bil to $23.4 bil

$4.12

$22.94 bil

0.3%

-2.6%

Guidance:

Consensus:

Eli Lilly Narrows Earnings Guidance

Eli Lilly & Co. said it now expects 2013 earnings of $4.10 to $4.15 per share and continues to expect revenue of $22.6 billion to $23.4 billion. The company's previous guidance was earnings of $4.05 to $4.15 per share and the current consensus earnings estimate is $4.12 per share on revenue of $22.94 billion for the year ending December 31, 2013.

In-line Guidance

FY 2014

1/7/20147:00:00 AM

$2.77 to $2.85

-0.7%

1.8%

Guidance:

Consensus:

Eli Lilly Sees 2014 In-line with Estimates

Eli Lilly & Co. said it expects 2014 earnings of $2.77 to $2.85 per share on revenue of $19.20 billion to $19.80 billion. The current consensus earnings estimate is $2.80 per share on revenue of $19.55 billion for the year ending December 31, 2014.

Reaffirms

FY 2014

1/30/20146:30:00 AM

$2.77 to $2.85

-1.2%

-2.5%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2014 earnings of $2.77 to $2.85 per share on revenue of $19.20 billion to $19.80 billion. The current consensus earnings estimate is $2.82 per share on revenue of $19.55 billion for the year ending December 31, 2014.

Revises Guidance with Acquisition

FY 2014

2/24/20148:00:00 AM

$2.72 to $2.80

$2.82

0.1%

1.6%

Guidance:

Consensus:

Eli Lilly Revises Guidance with Acquisition

Eli Lilly & Co. said with its acquisition of Lohmann SE, it now expects 2014 earnings of $2.72 to $2.80 per share. The company's previous guidance was earnings of $2.77 to $2.85 per share and the current consensus earnings estimate is $2.82 per share for the year ending December 31, 2014.

Reaffirms Below Estimates

FY 2014

4/24/20146:30:00 AM

$2.72 to $2.80

$2.81

-1.5%

2.2%

Guidance:

Consensus:

Eli Lilly Reaffirms Below Estimates

Eli Lilly & Co. said it continues to expect 2014 non-GAAP earnings of $2.72 to $2.80 per share. The current consensus earnings estimate is $2.81 per share for the year ending December 31, 2014.

Reaffirms

FY 2014

7/24/20146:30:00 AM

$2.72 to $2.80

$2.79

0.2%

-4.7%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2014 earnings of $2.72 to $2.80 per share. The current consensus earnings estimate is $2.79 per share for the year ending December 31, 2014.

Narrows Revenue Guidance

FY 2014

10/23/20146:30:00 AM

$2.72 to $2.80

$19.40 bil to $19.80 bil

$2.76

$19.77 bil

-0.5%

3.9%

Guidance:

Consensus:

Eli Lilly Narrows Revenue Guidance

Eli Lilly & Co. said it continues to expect 2014 earnings of $2.72 to $2.80 per share but now expects revenue of $19.40 billion to $19.80 billion. The company's previous guidance was revenue of $19.40 billion to $20.00 billion and the current consensus earnings estimate is $2.76 per share on revenue of $19.77 billion for the year ending December 31, 2014.

EPS In-line/Revenue Below

FY 2015

1/7/20157:30:00 AM

$3.10 to $3.20

-0.7%

-0.4%

Guidance:

Consensus:

Lilly Sees 2015 Revenue Below Estimates

Eli Lilly & Co. said it continues to expect 2014 non-GAAP earnings of $2.72 to $2.80 per share. The current consensus earnings estimate is $2.78 per share for the year ending December 31, 2014. The company also said it expects 2015 earnings of $3.10 to $3.20 per share on revenue of $20.3 billion to $20.8 billion. The current consensus earnings estimate is $3.16 per share on revenue of $20.88 billion for the year ending December 31, 2015.

EPS In-line/Revenue Below

FY 2015

1/30/20156:25:00 AM

$3.10 to $3.20

-0.2%

-3.6%

Guidance:

Consensus:

Lilly Lowers Revenue Guidance

Eli Lilly & Co. said it continues to expect 2015 earnings of $3.10 to $3.20 per share but now expects revenue of $19.5 billion to $20.0 billion. The company's previous guidance was revenue of $20.3 billion to $20.8 billion and the current consensus earnings estimate is $3.12 per share on revenue of $20.7 billion for the year ending December 31, 2015.

Reaffirms

FY 2015

4/23/20156:25:00 AM

$3.10 to $3.20

$19.5 bil to $20.0 bil

$3.15

$19.88 bil

0.1%

-1.4%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2015 earnings of $3.10 to $3.20 per share on revenue of $19.5 billion to $20.0 billion. The current consensus earnings estimate is $3.15 per share on revenue of $19.88 billion for the year ending December 31, 2015.

EPS Above Estimates

FY 2015

10/22/20156:25:00 AM

$3.40 to $3.45

$19.7 bil to $20.0 bil

$3.27

$19.93 bil

0.0%

6.2%

Guidance:

Consensus:

Eli Lilly Raises Guidance

Eli Lilly & Co. said it expects 2015 earnings of $3.40 to $3.45 per share on revenue of $19.7 billion to $20.0 billion. The company's previous guidance was earnings of $3.10 to $3.20 per share on revenue of $19.5 billion to $20.0 billion and the current consensus earnings estimate is $3.27 per share on revenue of $19.93 billion for the year ending December 31, 2015.

2016 Below Estimates

FY 2016

1/5/20166:45:00 AM

$3.45 to $3.55

1.5%

-3.0%

Guidance:

Consensus:

Eli Lilly Sees 2016 Below Estimates

Eli Lilly & Co. said it continues to expect 2015 non-GAAP earnings of $3.40 to $3.45 per share. The current consensus earnings estimate is $3.43 per share for the year ending December 31, 2015. The company also said it expects 2016 earnings of $3.45 to $3.55 per share on revenue of $20.2 billion to $20.7 billion. The current consensus earnings estimate is $3.62 per share on revenue of $21.47 billion for the year ending December 31, 2016.

Reaffirms

FY 2016

1/28/20166:25:00 AM

$3.45 to $3.55

-6.1%

-9.3%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.45 to $3.55 per share on revenue of $20.20 billion to $20.70 billion. The current consensus earnings estimate is $3.55 per share on revenue of $20.85 billion for the year ending December 31, 2016.

Raises Guidance In-line with Estimates

FY 2016

4/26/20166:25:00 AM

$3.50 to $3.60

$20.60 bil to $21.10 bil

$3.55

$20.65 bil

-2.1%

-0.5%

Guidance:

Consensus:

Eli Lilly Raises Guidance, but Remains In-line with Estimates

Eli Lilly & Co. said it expects 2016 earnings of $3.50 to $3.60 per share on revenue of $20.60 billion to $21.10 billion. The company's previous guidance was earnings of $3.45 to $3.55 per share on revenue of $20.20 billion to $20.70 billion and the current consensus earnings estimate is $3.55 per share on revenue of $20.65 billion for the year ending December 31, 2016.

Reaffirms

FY 2016

7/26/20166:25:00 AM

$3.50 to $3.60

$20.60 bil to $21.10 bil

$3.56

$20.90 bil

0.1%

0.7%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.50 to $3.60 per share on revenue of $20.60 billion to $21.10 billion. The current consensus earnings estimate is $3.56 per share on revenue of $20.90 billion for the year ending December 31, 2016.

Raises Guidance In-line with Estimates

FY 2016

10/25/20166:25:00 AM

$3.50 to $3.60

$20.80 bil to $21.20 bil

$3.59

$21.18 bil

0.2%

-5.1%

Guidance:

Consensus:

Eli Lilly Raises Revenue Guidance to be In-line with Estimates

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.50 to $3.60 per share but now expects revenue of $20.80 billion to $21.20 billion. The company's previous guidance was revenue of $20.60 billion to $21.10 billion and the current consensus earnings estimate is $3.59 per share on revenue of $21.18 billion for the year ending December 31, 2016.

EPS Above Estimates

FY 2017

12/15/20166:25:00 AM

$4.05 to $4.15

5.5%

4.1%

Guidance:

Consensus:

Eli Lilly Sees 2017 Earnings Above Estimates

Eli Lilly & Co. said it continues to expect 2016 earnings of $3.50 to $3.60 per share on revenue of $20.80 billion to $21.20 billion. The current consensus earnings estimate is $3.53 per share on revenue of $21.03 billion for the year ending December 31, 2016. The company also said it expects 2017 earnings of $4.05 to $4.15 per share on revenue of $21.80 billion to $22.30 billion. The current consensus earnings estimate is $3.99 per share on revenue of $22.02 billion for the year ending December 31, 2017.

Reaffirms

FY 2017

1/31/20176:25:00 AM

$4.05 to $4.15

3.1%

4.6%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2017 earnings of $4.05 to $4.15 per share on revenue of $21.80 billion to $22.30 billion. The current consensus earnings estimate is $4.10 per share on revenue of $22.00 billion for the year ending December 31, 2017.

Reaffirms

FY 2017

4/25/20176:25:00 AM

$4.05 to $4.15

$21.80 bil to $22.30 bil

$4.11

$22.25 bil

-2.7%

-1.2%

Guidance:

Consensus:

Eli Lilly Reaffirms

Eli Lilly & Co. said it continues to expect 2017 earnings of $4.05 to $4.15 per share on revenue of $21.80 billion to $22.30 billion. The current consensus earnings estimate is $4.11 per share on revenue of $22.25 billion for the year ending December 31, 2017.

Raises Guidance In-line with Estimates

FY 2017

7/25/20176:25:00 AM

$4.10 to $4.20

$22.0 bil to $22.50 bil

$4.12

$22.16 bil

-3.0%

-1.6%

Guidance:

Consensus:

Eli Lilly Raises Guidance but Remains In-line with Estimates

Eli Lilly & Co. said it expects 2017 earnings of $4.10 to $4.20 per share on revenue of $22.0 billion to $22.50 billion. The company's previous guidance was earnings of $4.05 to $4.15 per share on revenue of $21.80 billion to $22.30 billion and the current consensus earnings estimate is $4.12 per share on revenue of $22.16 billion for the year ending December 31, 2017.